MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), a biotechnology company developing artificial intelligence-driven voice analytics for drug and alcohol intoxication detection, announced the completion of manufacturing for its next-generation Edge AI Intoxication Detection Kiosk. The new hardware builds on a prototype developed in June and is designed to support the company’s proprietary Voice AI technology, which analyzes vocal characteristics to identify potential impairment. MindBio is continuing software integration, system testing and validation of its predictive models against conventional breath alcohol and oral fluid testing methods, with a potential initial commercial pilot targeted for later this year.
The company is developing the kiosk as a rapid, non-invasive alternative to conventional drug and alcohol screening, targeting safety-sensitive industries including mining, aviation, construction, heavy transport and law enforcement. MindBio aims to enable more frequent, large-scale workplace screening while potentially reducing testing costs, administration time and operational disruptions. The planned commercial pilot would provide an opportunity to evaluate the technology’s performance in a real-world environment against existing testing methods.
This development matters because traditional drug and alcohol testing can be time-consuming, invasive, and costly, often requiring dedicated personnel and causing workflow interruptions. In industries where safety is paramount, such as mining and aviation, impairment can lead to catastrophic accidents. A non-invasive, AI-driven solution could allow for more frequent and widespread screening, potentially deterring impairment and enhancing workplace safety. Moreover, the scalability of the kiosk could make it feasible to test larger numbers of employees regularly, something that is often impractical with conventional methods.
MindBio’s AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication in a range of enterprise environments, including the mining industry, aviation, construction and law enforcement. For investors, the completion of manufacturing marks a significant milestone toward commercialization. The successful deployment of the kiosk could open up a large addressable market, given the widespread need for efficient impairment detection across various sectors. However, the technology still requires validation against conventional methods, and regulatory acceptance will be crucial.
The latest news and updates relating to MBQIF are available in the company’s newsroom at https://nnw.fm/MBQIF. The full press release can be viewed at https://nnw.fm/15cJf.
This announcement was disseminated by NetworkNewsWire ("NNW"), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries, among other services. For more information, please visit https://www.NetworkNewsWire.com.
